Ljubic Nemanja, Ueberberg Bianca, Grunze Heinz, Assion Hans-Jörg
Bereich Forschung & Wissenschaft, LWL-Klinik, Marsbruchstr. 179, 44287, Dortmund, Germany.
Psychiatrie Schwäbisch Hall, Ringstraße. 1, 74523, Schwäbisch Hall, Germany.
Ann Gen Psychiatry. 2021 Sep 21;20(1):45. doi: 10.1186/s12991-021-00367-x.
Old age bipolar disorder has been an orphan of psychiatric research for a long time despite the fact that bipolar disorder (BD)-I and II together may affect 0.5-1.0% of the elderly. It is also unclear whether aetiology, course of illness and treatment should differ in patients with a first manifestation in older age and patients suffering from a recurrence of a BD known for decades. This narrative review will summarize the current state of knowledge about the epidemiology, clinical features, and treatment of BD in the elderly.
We conducted a Medline literature search from 1970 to 2021 using MeSH terms "Bipolar Disorder" × "Aged" or "Geriatric" or "Elderly". Search results were complemented by additional literature retrieved from examining cross references and by hand search in text books. Varying cut-off ages have been applied to differentiate old age from adult age BD. Within old age BD, there is a reasonable agreement of distinct entities, early and late-onset BD. They differ to some extent in clinical symptoms, course of illness, and some co-morbidities. Point prevalence of BD in older adults appears slightly lower than in working-age adults, with polarity of episodes shifting towards depression. Psychopharmacological treatment needs to take into account the special aspects of somatic gerontology and the age-related change of pharmacokinetic and pharmacodynamic characteristics. The evidence for commonly used treatments such as lithium, mood-stabilizing antiepileptics, antipsychotics, and antidepressants remains sparse. Preliminary results support a role of ECT as well as psychotherapy and psychosocial interventions in old age BD.
There is an obvious need of further research for all treatment modalities of BD in old age. The focus should be pharmacological and psychosocial approaches, as well as their combination, and the role of physical treatment modalities such as ECT.
尽管双相情感障碍(BD)I型和II型合起来可能影响0.5%-1.0%的老年人,但老年双相情感障碍长期以来一直是精神病学研究的冷门领域。首次发病于老年的患者与罹患双相情感障碍数十年后复发的患者在病因、病程及治疗方面是否存在差异也尚不清楚。本叙述性综述将总结有关老年双相情感障碍的流行病学、临床特征及治疗的当前知识状态。
我们使用医学主题词“双相情感障碍”ד老年人”或“老年病学”或“老年人”对1970年至2021年的医学文献数据库进行了检索。通过检查交叉参考文献获取的其他文献以及教科书的手工检索对检索结果进行了补充。已采用不同的年龄界限来区分老年双相情感障碍与成年双相情感障碍。在老年双相情感障碍中,早期和晚期发病的双相情感障碍这两个不同实体存在合理的共识。它们在临床症状、病程及一些合并症方面存在一定程度的差异。老年双相情感障碍的点患病率似乎略低于工作年龄成年人,发作极性向抑郁转变。精神药物治疗需要考虑老年躯体医学的特殊方面以及药代动力学和药效学特征的年龄相关变化。锂盐、心境稳定剂抗癫痫药、抗精神病药及抗抑郁药等常用治疗方法的证据仍然不足。初步结果支持电休克治疗以及心理治疗和心理社会干预在老年双相情感障碍中的作用。
老年双相情感障碍的所有治疗方式显然都需要进一步研究。重点应是药物治疗和心理社会方法及其联合应用,以及电休克治疗等物理治疗方式的作用。